United States Ligases Market Report 2016

October 2016 | 124 pages | ID: U3B75722999EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ligases

Revenue, means the sales value of Ligases

This report studies sales (consumption) of Ligases in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Thermo Fisher Scientific, Inc. (U.S.)
• Merck KGaA (Germany)
• New England Biolabs, Inc. (U.S.)
• Promega (U.S.)
• Illumina, Inc. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• F. Hoffmann-la Roche Ltd. (Switzerland)
• Takara Bio Inc. (Japan)
• QIAGEN N.V. (The Netherlands)
• Becton, Dickinson and Company (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Ligases in each application, can be divided into

• PCR
• Sequencing
• Cloning

Contents

United States Ligases Market Report 2016

1 LIGASES OVERVIEW

1.1 Product Overview and Scope of Ligases
1.2 Classification of Ligases
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Ligases
  1.3.1 PCR
  1.3.2 Sequencing
  1.3.3 Cloning
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Ligases (2011-2021)
  1.4.1 United States Ligases Sales and Growth Rate (2011-2021)
  1.4.2 United States Ligases Revenue and Growth Rate (2011-2021)

2 UNITED STATES LIGASES COMPETITION BY MANUFACTURERS

2.1 United States Ligases Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Ligases Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Ligases Average Price by Manufactures (2015 and 2016)
2.4 Ligases Market Competitive Situation and Trends
  2.4.1 Ligases Market Concentration Rate
  2.4.2 Ligases Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES LIGASES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Ligases Sales and Market Share by Type (2011-2016)
3.2 United States Ligases Revenue and Market Share by Type (2011-2016)
3.3 United States Ligases Price by Type (2011-2016)
3.4 United States Ligases Sales Growth Rate by Type (2011-2016)

4 UNITED STATES LIGASES SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Ligases Sales and Market Share by Application (2011-2016)
4.2 United States Ligases Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES LIGASES MANUFACTURERS PROFILES/ANALYSIS

5.1 Thermo Fisher Scientific, Inc. (U.S.)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Ligases Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Thermo Fisher Scientific, Inc. (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck KGaA (Germany)
  5.2.2 Ligases Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck KGaA (Germany) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 New England Biolabs, Inc. (U.S.)
  5.3.2 Ligases Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 New England Biolabs, Inc. (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Promega (U.S.)
  5.4.2 Ligases Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Promega (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Illumina, Inc. (U.S.)
  5.5.2 Ligases Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Illumina, Inc. (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Agilent Technologies, Inc. (U.S.)
  5.6.2 Ligases Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Agilent Technologies, Inc. (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 F. Hoffmann-la Roche Ltd. (Switzerland)
  5.7.2 Ligases Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 F. Hoffmann-la Roche Ltd. (Switzerland) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Takara Bio Inc. (Japan)
  5.8.2 Ligases Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Takara Bio Inc. (Japan) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 QIAGEN N.V. (The Netherlands)
  5.9.2 Ligases Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 QIAGEN N.V. (The Netherlands) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Becton, Dickinson and Company (U.S.)
  5.10.2 Ligases Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Becton, Dickinson and Company (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 LIGASES MANUFACTURING COST ANALYSIS

6.1 Ligases Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Ligases

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Ligases Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Ligases Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES LIGASES MARKET FORECAST (2016-2021)

10.1 United States Ligases Sales, Revenue Forecast (2016-2021)
10.2 United States Ligases Sales Forecast by Type (2016-2021)
10.3 United States Ligases Sales Forecast by Application (2016-2021)
10.4 Ligases Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ligases
Table Classification of Ligases
Figure United States Sales Market Share of Ligases by Type in 2015
Table Application of Ligases
Figure United States Sales Market Share of Ligases by Application in 2015
Figure PCR Examples
Figure Sequencing Examples
Figure Cloning Examples
Figure United States Ligases Sales and Growth Rate (2011-2021)
Figure United States Ligases Revenue and Growth Rate (2011-2021)
Table United States Ligases Sales of Key Manufacturers (2015 and 2016)
Table United States Ligases Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ligases Sales Share by Manufacturers
Figure 2016 Ligases Sales Share by Manufacturers
Table United States Ligases Revenue by Manufacturers (2015 and 2016)
Table United States Ligases Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Ligases Revenue Share by Manufacturers
Table 2016 United States Ligases Revenue Share by Manufacturers
Table United States Market Ligases Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Ligases Average Price of Key Manufacturers in 2015
Figure Ligases Market Share of Top 3 Manufacturers
Figure Ligases Market Share of Top 5 Manufacturers
Table United States Ligases Sales by Type (2011-2016)
Table United States Ligases Sales Share by Type (2011-2016)
Figure United States Ligases Sales Market Share by Type in 2015
Table United States Ligases Revenue and Market Share by Type (2011-2016)
Table United States Ligases Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ligases by Type (2011-2016)
Table United States Ligases Price by Type (2011-2016)
Figure United States Ligases Sales Growth Rate by Type (2011-2016)
Table United States Ligases Sales by Application (2011-2016)
Table United States Ligases Sales Market Share by Application (2011-2016)
Figure United States Ligases Sales Market Share by Application in 2015
Table United States Ligases Sales Growth Rate by Application (2011-2016)
Figure United States Ligases Sales Growth Rate by Application (2011-2016)
Table Thermo Fisher Scientific, Inc. (U.S.) Basic Information List
Table Thermo Fisher Scientific, Inc. (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific, Inc. (U.S.) Ligases Sales Market Share (2011-2016)
Table Merck KGaA (Germany) Basic Information List
Table Merck KGaA (Germany) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck KGaA (Germany) Ligases Sales Market Share (2011-2016)
Table New England Biolabs, Inc. (U.S.) Basic Information List
Table New England Biolabs, Inc. (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
Table New England Biolabs, Inc. (U.S.) Ligases Sales Market Share (2011-2016)
Table Promega (U.S.) Basic Information List
Table Promega (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Promega (U.S.) Ligases Sales Market Share (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information List
Table Illumina, Inc. (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (U.S.) Ligases Sales Market Share (2011-2016)
Table Agilent Technologies, Inc. (U.S.) Basic Information List
Table Agilent Technologies, Inc. (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies, Inc. (U.S.) Ligases Sales Market Share (2011-2016)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-la Roche Ltd. (Switzerland) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Ligases Sales Market Share (2011-2016)
Table Takara Bio Inc. (Japan) Basic Information List
Table Takara Bio Inc. (Japan) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takara Bio Inc. (Japan) Ligases Sales Market Share (2011-2016)
Table QIAGEN N.V. (The Netherlands) Basic Information List
Table QIAGEN N.V. (The Netherlands) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
Table QIAGEN N.V. (The Netherlands) Ligases Sales Market Share (2011-2016)
Table Becton, Dickinson and Company (U.S.) Basic Information List
Table Becton, Dickinson and Company (U.S.) Ligases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Becton, Dickinson and Company (U.S.) Ligases Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ligases
Figure Manufacturing Process Analysis of Ligases
Figure Ligases Industrial Chain Analysis
Table Raw Materials Sources of Ligases Major Manufacturers in 2015
Table Major Buyers of Ligases
Table Distributors/Traders List
Figure United States Ligases Production and Growth Rate Forecast (2016-2021)
Figure United States Ligases Revenue and Growth Rate Forecast (2016-2021)
Table United States Ligases Production Forecast by Type (2016-2021)
Table United States Ligases Consumption Forecast by Application (2016-2021)